InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Hoffman Robert E., Chairman & CEO. Director active across 1 companies, notably Kintara Therapeutics, Inc.. Aggregated, 2 reports have been published. Total volume traded: €46k. The latest transaction was filed on 15 February 2022 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations2 total
€22,81555,000 shares@ €0.414850.0% of flow
Common Stock
SEC:0000905718-22-000393:0·
Ideal exit: 12 Nov 2022 (T+270)
€22,81555,000 shares@ €0.4148100.0% of flow
Common Stock
SEC:0000905718-22-000393·
Ideal exit: 12 Nov 2022 (T+270)
2 of 2 declarations
About Hoffman Robert E.
Hoffman Robert E. is the President and CEO of Kintara Therapeutics, Inc. He is responsible for the strategic direction of the company, ensuring that development objectives are met. His leadership is essential for navigating the biotechnology sector.
